Jonathan Chou (UCSF) continuing the theme of deciphering mechanisms behind response/resistance to ADCs in urothelial bladder cancer: proposing a priming step with PPARy antagonists to increase Nectin4 surface expression on bladder cancer cells. Many Do Not Post Slides 🤷🏼‍♂️ #AACR26 https://t.co/a71aV7Cb9V